The serine-threonine kinase Akt exerts its anti-apoptotic eects through several downstream targets, including the pro-apoptotic Bc1-2 family member Bad, Forkhead transcription factors, and the cyclic AMP response element-binding protein (CREB). In this report we demonstrate that Akt inhibits a conformational change in the pro-apoptotic Bax protein and its translocation to mitochondria, thus preventing the disruption of the mitochondrial inner membrane potential (DC m ), caspase-3 activation, and apoptosis in pre-B hematopoietic cells FL5.12 following interleukin-3 (IL-3) withdrawal. Inhibition of PI-3 kinase, but not MAPK kinase, promotes this conformational change in Bax. Moreover, overexpression of Akt suppresses the relocalization of GFP-Bax to mitochondria and apoptosis in Hela cells induced by the DNA-damaging agent methyl methanesulphonate. However, Akt does not abolish the ability of a conformationally changed Bax mutant, GFP-Bax (DS184), to translocate to mitochondria and to induce apoptosis. These ®ndings indicate that Akt exerts its anti-apoptotic eects in cells at a premitochondrial stage, at least in part, by inhibiting Bax conformational change and its redistribution to the mitochondrial membranes. Oncogene (2001) 20, 7779 ± 7786.
Introduction
The Bc1-2 family of proteins regulates apoptosis at least in part by controlling the mitochondrial integrity and the release of pro-apoptotic molecules such as cytochrome c and AIF into the cytosol (Green and Reed, 1998; Gross et al., 1999; Vander Heiden and Thompson, 1999) . The anti-apoptotic proteins such as Bc1-2 and Bc1-x L tend to prevent the release of cytochrome c from mitochondria and subsequent caspase activation, whereas the proapoptotic proteins such as Bax and Bid promote these events. Apoptotic stimuli induce intracellular translocation of pro-apoptotic Bc1-2 family members from cytoplasm to the surface of mitochondria where they interact with other members of this family and cause mitochondrial dysfunction (Gross et al., 1999; Porter, 1999; Reed, 1998) .
In order to avoid apoptosis, cells require survival signals that depend on extracellular stimuli such as certain growth factors, cytokines or cell-matrix contact (Ra, 1992) . The lipid kinase PI3-K (phosphatidylinositol 3-kinase) plays a critical role in the intracellular signaling cascades mediated by survival factors through producing phosphoinositol phospholipid second messengers that activate downstream targets (Datta et al., 1999; . Among the downstream eectors of PI3-K is the serine-threonine kinase Akt/the protein kinase B, which is regulated by binding to the phospholipid products (PtdIns-3,4-P 2 and PtdIns-3,4,5-P 3 ) as well as by phosphorylation through the phosphoinositide dependent kinase-1 (PDK-1) at the plasma membrane (Chan et al., 1999; . Activated Akt promotes cell survival in a variety of cell types and prevents apoptosis induced by various apoptotic stimuli (Datta et al., 1999; Khwaja, 1999) . Several downstream targets of Akt, including GSK-3, Bad, caspase-9, and transcription factors such as CREB, FKHRL1 and NF-kB, have been identi®ed as possible mechanisms by which Akt promotes cell survival and blocks apoptosis (Datta et al., 1999; Khwaja 1999) . We provide evidence here that Akt inhibits a conformational change of the pro-apoptotic Bc1-2 family member Bax and its subsequent translocation to mitochondria, thus preventing alterations in mitochondrial membrane potential, cytochrome c release, caspase activation, and apoptosis.
Results

Akt maintains mitochondrial integrity and prevents caspase activation induced by IL-3 deprivation
In order to further understand the mechanism by which Akt promotes cell survival, we stably expressed a constitutively active form of Akt containing the myristoylation/palmitylation (m/p) motif from the tyrosine kinase Lck (m/p-Akt) (Andjelkovic et al., 1997) in murine lymphoid progenitor FL5.12 cells. Consistent with previous report (Songyang et al., 1997) , overexpression of active Akt clearly protected FL5.12 cells from cell death induced by IL-3 deprivation ( Figure 1a) . These results were con®rmed by Annexin V-staining assay, in which Annexin V positive cells were determined as apoptosis. As shown in Figure 1b , only *15% of FL5.12 cells expressing the m/p-Akt protein were Annexin V positive, compared to *65% of FL5.12-Neo cells, when cultured in the absence of IL-3 for 16 h.
Next, we determined the ability of m/p-Akt to inhibit caspase activation and the loss of mitochondrial integrity in FL5.12 cells following IL-3 deprivation. A cell-permeable¯uorigenic caspase substrate PhiPhiLux-G 2 D 2 was used to evaluate caspase activation in intact FL5.12 transfectants after IL-3 withdrawal. As shown in Figure 2a , only *22% of FL5.12-m/p-Akt cells produced¯uorescence emissions when deprived of IL-3 for 18 h, compared to nearly 60% of FL5.12-Neo control cells apparently cleaved the PhiPhiLux-G2D2 substrate. To con®rm the¯ow cytometric results, caspase activation was examined by immunoblotting with antibodies speci®c for caspase-3 and the cleaved D4-GDI caspase substrate. As shown in Figure 2b , the protein levels of pro-caspase-3 dramatically decreased in FL5.12-Neo cells when cultured in the absence of IL-3. Moreover, cleavage of D4-GDI demonstrated further the activation of caspase in FL5.12-Neo cells following IL-3 withdrawal (Figure 2b ). In contrast, the process of caspase-3 activation and the cleavage of D4-GDI were apparently suppressed in FL5.12 cells expressing the m/p-Akt protein (Figure 2b ).
To determine whether Akt prevents the disruption of mitochondrial integrity, the mitochondrial inner membrane potential (DC m ) was assessed by using a cationic mitochondrion-selective dye MitoTracker CMTMRos. Flow cytometric analysis of MitoTracker CMTMRos dye-stained cells showed that *65% of FL5.12-Neo cells lost the ability to uptake this cationic mitochondria speci®c dye when cultured without IL-3 for 18 h, whereas *88% of FL5.12-m/p-Akt cells remained with intact mitochondrial membrane potential (Figure 2c ).
These results, together with the previous report (Kennedy et al., 1999) , indicate that Akt suppresses cell death by maintaining mitochondrial integrity and inhibiting caspase activation.
Akt inhibits Bax conformational change and its translocation to mitochondria following IL-3 withdrawal Bax is a pro-apoptotic member of the Bc1-2 protein family and accelerates apoptosis induced by a variety of stimuli (Oltvai et al., 1993) . During apoptosis, the cytosolic and monomeric Bax translocates to the mitochondrial membranes (Goping et al., 1998; Wolter et al., 1997) and causes the loss of mitochondrial membrane potential and subsequent cytochrome c release and caspase activation (Narita et al., 1998; Shimizu et al., 1999) . In addition, Bax translocation was also observed in FL5.12 cells when cultured in the absence of IL-3 . Moreover, it has been shown that apoptotic stimuli induce a conformational change of Bax prior to its translocation to mitochondria where it inserts as a homodimer (Hsu and Youle, 1998; Murphy et al., 2000 , Nechushtan et al., 1999 . We therefore explored the possibility that m/p-Akt might prevent apoptosis by inhibiting Bax conformational change and its subsequent translocation to mitochondria.
In order to investigate Bax conformational change, immuno¯uorescence analysis was carried out with antiBax monoclonal antibody 6A7 that speci®cally recognizes the conformationally changed Bax protein Youle, 1997, 1998; Murphy et al., 2000) . When cultured in the presence of IL-3, both FL5.12-m/p-Akt and FL5.12-Neo transfectants exhibited negative for Bax staining with 6A7 (Figure 3b,h ). In contrast, after 12 h of IL-3 withdrawal, FL5.12-Neo control cells were strongly stained by the anti-Bax 6A7 antibody and a proportion of 6A7 positive Bax colocalized with mitochondria, indicating that Bax underwent a conformational change and intracellular translocation to mitochondria (Figure 3e,f) . Furthermore, some of these cells exhibited nuclear fragmentation, typical apoptotic morphology, as indicated by arrowhead Figure 3k ). These results were further con®rmed by immunoprecipitation experiments, in which FL5.12 cells were cultured with or without IL-3 for 12 h and subjected to immunoprecipitation with anti-Bax 6A7 antibody in the presence of either 1% Chaps or 1% Triton X-100. The zwitterionic detergent Chaps has been shown to keep Bax in its native conformation, whereas nonionic detergents such as Nonidet P-40 and Triton X-100 induce a conformational change in the Bax protein . When cultured with IL-3, no or very little Bax was detected in the immunoprecipitates from Chaps cell lysates, although it could be immunoprecipitated in the presence of Triton X-100 ( Figure 3m ). Following IL-3 withdrawal, a large proportion of Bax was immunoprecipitated with 6A7 antibody from FL5.12-Neo cell lysates prepared with 1% Chaps (Figure 3m , lane 3), indicating that IL-3 deprivation induced Bax conformational change in FL5.12-Neo cells. However, IL-3 deprivation failed to induce Bax conformational change in FL5.12 cells expressing m/p-Akt ( Figure 3m , lane 6).
To further assess the redistribution of Bax to mitochondria following the withdrawal of IL-3, subcellular fractionation/immunoblot analysis was performed in FL5.12-m/p-Akt and FL5.12-Neo control cells in the presence or absence of IL-3 using isotonic lysis buer. When cultured with IL-3, a substantial proportion of Bax was detected in both the cytosolic fraction (S) and the mitochondria-enriched heavy membrane (M) fraction (Figure 3n ), consistent with the previous results . However, most (480%) of the Bax protein was found in the heavy membrane fraction of FL5.12-Neo cells after 12 h of IL-3 withdrawal (Figure 3n, lane 4) . This intracellular translocation of Bax was accompanied by the release of cytochrome c from the mitochondria to the cytosol (Figure 3n , lane 5). In contrast, neither Bax translocation nor cytochrome c release was detected in FL5.12 cells expressing m/p-Akt (Figure 3n , lanes 7 ± 12). Moreover, the anti-apoptotic Bc1-2 protein was constitutively found in the mitochondria-enriched heavy membrane fraction regardless of cell cultures with or without IL-3 (Figure 3n ), consistent with the results of .
Inhibition of PI-3K but not MAPK kinase induces Bax conformational change
IL-3 receptor stimulation activates multiple downstream signaling pathways, including the Jak/Stat, Ras/Raf-1/MEK/MAPK, and PI-3K/Akt pathways, which play important roles in cellular proliferation and survival (Reddy et al., 2000) . To assess whether these pathways contribute to the prevention of Bax conformational change in FL5.12 cells, a panel of kinase inhibitors was used. As shown in Figure 4a , the PI-3K inhibitors LY294002 and Wortmannin induced Bax conformational change in FL5.12 cells as demonstrated by immunoprecipitation with 6A7 anti-Bax antibody. Inhibition of PI-3K was sucient to kill *30% of cells even in the presence of IL-3, suggesting that this lipid kinase is a major regulator in the IL-3-mediated cell survival pathways. Moreover, treating FL5.12 cells with Wortmannin or LY294002 in the absence of IL-3 potentiated Bax conformational change and sensitized cells to apoptosis (Figure 4b ). In contrast, the MAPK kinase inhibitor PD98059 had no or very little eect on Bax conformational change in Figure 2 Akt inhibits caspase-3 activation, D4-GDI cleavage and the loss of mitochondrial membrane potential (DC m ). FL5.12-Neo and FL5.12-m/p-Akt cells were cultured in the presence or absence of IL-3 for 18 h prior to the following analysis. In (a), cells were incubated with a¯uorigenic caspase substrate PhiPhiLux-G2D2 for 1 h and analysed by¯uorescence-activated cell sorter. In (b), cell lysates were prepared with Triton X-100 lysis buer containing protease inhibitors and analysed by SDS ± PAGE/immunoblotting with monoclonal antibodies speci®c for caspase-3, cleaved D4-GDI or b-actin control protein. In (c), cells were incubated with 25 nM membrane-permeable mitochondria speci®c dye MitoTracker CMTMRos for 30 min and analysed by¯ow cytometry to evaluate the mitochondrial inner membrane potential (DC m ) FL5.12 cells regardless of the presence or absence of IL-3 (Figure 4a,b) . Although the eects of PD98059 were less marked than those observed with PI-3K inhibitors, blockade of MAPK kinase caused cell death (Figure 4a,b) , suggesting that the intracellular signaling pathway mediated by this protein kinase also contributes to the survival of IL-3-dependent hematopoietic cells.
Akt inhibits cell death at a premitochondrial stage
To determine whether Akt regulates cell survival and apoptosis by controlling the apoptosis cascade before Bax translocation to mitochondria, we transiently coexpressed Bax as a GFP fusion protein with or without Akt in Hela cells. Consistent with previous report (Nechushtan et al., 1999) , the GFP-Bax fusion protein revealed a diuse pattern throughout the cytosol in healthy cells (Figure 5a,g ), and became punctate and mitochondria-associated in apoptotic cells (Figure  5d,f) . Overexpression of a constitutively active Akt prevented the redistribution of GFP-Bax to mitochondria (Figure 5j ± l) and suppressed cell death induced by the DNA-damaging agent methyl methanesulphonate (MMS) (Figure 5m ). In contrast, cells expressing GFPBax(DS), a conformationally changed Bax mutant lacking the Ser184 residue that is believed to be most important in controlling Bax subcellular localization (Nechushtan et al., 1999) , showed a mitochondriabound and punctate pattern of¯uorescence (Figure 5n ± p) and died by apoptosis (Figure 5t) . Moreover, the ability of this Bax mutant to translocate to mitochondria and to induce apoptosis was not suppressed by overexpression of Akt (Figure 5q ± t) .
Akt prevents Bid cleavage and Bax association with Bif-1
Bid is another pro-apoptotic member of the Bc1-2 family of proteins, which heterodimerizes with both Bc1-2 and Bax (Wang et al., 1996) . Apoptotic stimuli induce Bid cleavage and the resulting truncated tBid plays a role in induction of Bax conformational change (Desagher et al., 1999; Heibein et al., 2000; Li et al., 1998; Luo et al., 1998; Perez and White, 2000; Sutton et al., 2000) . Thus, we examined the eect of Akt on Bid cleavage in FL5.12 cells by immunoblot analysis. As shown in Figure 6a , the protein levels of Bid clearly decreased and a cleaved fragment tBid was detected in FL5.12-Neo cells following IL-3 deprivation. However, IL-3 withdrawal-induced Bid cleavage was suppressed in FL5.12 cells expressing active Akt (Figure 6a, lane  4) .
In addition, we have recently reported that induction of apoptosis results in increased association of Bax with Bif-1 in FL5.12 cells and that overexpression of Bif-1 promotes Bax conformational change and apoptosis following IL-3 deprivation (Cuddeback et al., 2001 ). To determine whether Akt prevents Bax Figure 3 Akt suppresses Bax conformational change and its translocation to mitochondria. In a to l, FL5.12-Neo (a ± f) and FL512-m/p-Akt (g ± l) were cultured in the presence (a ± c, g ± i) or absence (d ± f, j ± l) of IL-3 for 12 h. After 30 min incubation with MitoTracker Red dye, cells were ®xed and stained with anti-Bax 6A7 monoclonal antibody, followed by FITC-labeled goat antimouse IgG secondary antibody and¯uorescence microscopic analysis. The nuclear morphology was examined by DAPI staining and the apoptotic cells are indicated by arrowhead. (m) Stably transfected FL5.12 cells were cultured without IL-3 for 12 h and lysed with buer containing 1% Triton X-100 or 1% Chaps. The conformationally changed Bax protein was immunoprecipitated using anti-Bax 6A7 antibody and detected by immunoblotting with anti-Bax rabbit antiserum. In addition to immune complexes (IP), 50 mg of post-immunoprecipitation lysates (Sup) was applied directly to SDS ± PAGE/immunoblot analysis. (n) FL5.12-Neo and FL5.12-m/p-Akt cells were cultured in the absence of IL-3 for the indicated times prior to subcellular fractionation. The cytosolic (S) and heavy membrane (M) fractions were normalized for protein content and subjected to SDS ± PAGE/immunoblot analysis with antibodies speci®c for Bax, Bc1-2 or cytochrome c heterodimerization with Bif-1, we performed coimmunoprecipitation experiments with anti-Bax polyclonal rabbit antiserum. As shown in Figure 6b , increased association of Bax with Bif-1 was observed in FL5.12-Neo control cells but not in FL5.12-m/p-Akt cells following IL-3 withdrawal, indicating that Akt prevents Bif-1 binding to Bax in response to apoptotic signal.
Discussion
Our results indicate that Akt regulates cell survival and apoptosis at a premitochondrial stage, at least in part, by preventing Bax conformational change and its translocation to mitochondria. In healthy cells (at least some types of cells), the Bax protein resides largely in the cytosol, despite the presence of a typical membrane-anchoring sequence near its C-terminus Wolter et al., 1997) . Apoptotic stimuli induce a conformational change of the Bax protein, resulting in exposure of its N-and C-termini that appears to be required for its insertion into mitochondrial membranes (Nechushtan et al., 1999) . Once integrated into membranes, Bax can form dimers and larger oligomers, causing cytochrome c release and apoptotic cell death ).
Akt is a major regulator of the survival signaling cascades mediated by growth factors and cytokines, which exerts its anti-apoptotic eects in a variety of ways. One mechanism whereby Akt functions to promote cell survival is through phosphorylation and inactivation of pro-apoptotic proteins such as Bad, caspase-9, and possibly Apaf-1 (Cardone et al., 1998; Datta et al., 1997; del Peso et al., 1997; Zhou et al., 2000) . Bad is a pro-apoptotic member of the Bc1-2 protein family that promotes apoptosis through heterodimerization with anti-apoptotic proteins such as Bc1-2 and Bc1-x L (Yang et al., 1995) . Phosphorylation of Bad by Akt at serine residues 112 and 136 results in its dissociation from Bc1-x L and translocation to the cytosol where it binds to 14-3-3 proteins, thus promoting cell survival (Datta et al., 1997; del Peso et al., 1997) . Consistent with this model, our results, together with the previous report (Kennedy et al., 1999) , demonstrate that Akt suppresses cell death by regulating mitochondrial integrity. However, there is no or very little (if any) endogenous Bad protein in FL5.12 cells (not shown), thus this may not be the primary mechanism used by Akt to protect this hematopoietic cell line from apoptosis triggered by IL-3 deprivation. On the other hand, the ability of Akt to phosphorylate caspase-9 and Apaf-1 would provide a potential mechanism for Akt to regulate apoptosis at a postmitochondrial level downstream of cytochrome c and before caspase-9 activation (Zhou et al., 2000) . Another mechanism by which Akt mediates cell survival and apoptosis is through regulation of transcription factors. Akt has been shown to directly phosphorylate and inactivate the Forkhead transcription factor family member FKHRL1, resulting in decreased Fas ligand transcription and promoting cell survival . Phosphorylation and activation of IkB kinase by Akt promotes IkB degradation, allowing NF-kB to activate transcription of anti-apoptotic genes (Ozes et al., 1999; Romashkova and Makarov, 1999) .
Cytokines mediate cell survival through multiple independent signaling pathways. It has been reported that the expression levels of Bc1-x L are downregulated by cytokine withdrawal in murine IL-3-dependent cells (Kuribara et al., 1999; Leverrier et al., 1997) . IL-3 withdrawal from the culture of FL5.12 cells also results in activation of the pro-apoptotic protein Bax by promoting its mitochondrial translocation and homodimerization . This event is associated with a conformational change of the Bax protein that leads to the exposure of its N-and Ctermini and is accompanied by the mitochondrial dysfunction and the release of cytochrome c into the cytosol (Murphy et al., 2000; Nechushtan et al., 1999) . Our studies indicate that IL-3-mediated PI-3K/Akt signaling pathway contributes to regulation of Bax conformation. Using anti-Bax 6A7 antibody, which only recognizes the conformationally changed Bax protein, showed that Bax are inactive in FL5.12 cells supplemented with exogenous IL-3, although Bax can be detected in both the cytosolic fraction and the Figure 4 Inhibition of PI-3 kinase induces Bax conformational change. FL5.12 cells were cultured in the presence (a) or absence (b) of IL-3 with the indicated inhibitors or DMSO as control. Cell lysates were prepared at 24 h (a) or 8 h (b) later with Chaps lysis buer containing protease inhibitors and subjected to immunoprecipitation with anti-Bax 6A7 antibody and SDS ± PAGE/ immunoblot analysis with anti-Bax rabbit antiserum. The cell viability was determined at 24 h by trypan blue dye exclusion mitochondria-enriched heavy membrane fraction (Figure 3) . Consistently, it has been reported that in Hela as well as cerebellar granule cells Bax is predominantly associated with mitochondria as a native/inactive form and it undergoes a conformational change upon the Bid binding on this organelle (Desagher et al., 1999) . Expression of a constitutively active Akt inhibited Bax conformational change and its translocation to mitochondria in cells, thus preventing the loss of mitochondrial membrane potential, cytochrome c release and caspase activation. Conversely, inhibiting of PI-3 kinase, but not MAPK kinase, promoted Bax conformational change (Figure 4) . Moreover, Akt was unable to prevent the mitochondria targeting of a conformationally changed Bax mutant and failed to inhibit apoptosis induced by this constitutively mitochondria-docking Bax protein ( Figure 5 ).
Taken together, our ®ndings suggest that Akt protects cells from apoptosis at a premitochondrial stage, at least in part, through inhibition of a conformational change in the pro-apoptotic Bax protein. However, how Akt suppresses Bax conformational change remains unclear. It seems unlikely that Akt inactivates Bax by phosphorylating this proapoptotic protein directly, because Bax lacks Akt phosphorylation sites and there is no reported evidence Stably transfected FL5.12 cells were cultured with or without IL-3 for 18 h and lysed in Chaps lysis buer containing protease inhibitors. In (a), cell lysates (30 mg of protein per lane) were analysed by SDS ± PAGE/immunoblot with anti-Bid antibody. In (b), immunoprecipitation (IP) was performed using anti-Bax polyclonal antiserum and followed by immunoblot analysis with antibodies speci®c for Bax or Bif-1. In addition to immune complexes, the total lysates (30 mg of protein per lane) were applied directly to SDS ± PAGE/immunoblot analysis of Bax phosphorylation in cells. It has been shown that the BH3-only pro-apoptotic protein Bid undergoes proteolysis during apoptosis and the truncated tBid contributes to Bax conformational change and mitochondrial translocation (Desagher et al., 1999; Perez and White, 2000) . Interestingly, expression of a constitutively active Akt inhibited Bid cleavage in FL5.12 cells following IL-3 deprivation (Figure 6a ). In addition to Bid, we have recently shown that Bif-1 binding to Bax may have a role in Bax conformational change (Cuddeback et al., 2001 ). Thus, it is possible that Akt directly interferes with the interaction of Bax with Bid or Bif-1 that regulates Bax conformation and its subcellular localization in cells. Indeed, IL-3 withdrawal failed to induce Bif-1 binding to Bax in FL5.12 cells expressing active Akt (Figure 6b ). Additional studies, however, will be required to fully delineate the biochemical mechanisms by which Akt regulates the Bax-mediated pathway for apoptosis.
Materials and methods
Cell culture and transfection
FL5.12 cells were grown in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS), 10% WEHI3B conditioned medium as a source of IL-3 and antibiotics. Hela cells were sustained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% FCS and antibiotics. Hela cells were transfected by a calcium phosphate method and FL5.12 cells were transfected by electroporation as described previously (Cuddeback et al., 2001) . Plasmids pcDNA3-Lck(m/p) were prepared by inserting the Lck myristoylation/palmitylation (m/p) signal sequences (Andjelkovic et al., 1997) into the pcDNA3 vector (Invitrogen). The Akt cDNA was ampli®ed by polymerase chain reaction (PCR) with pCMV6-Akt (Wang et al., 1999) as the template and inserted into the pcDNA3-Lck(m/p) vector. After con®rming the nucleotide sequences, the chimeric cDNA encoding m/p-Akt fusion protein was subcloned into the pEF-neo vector. The GFP-Bax expression plasmids pEGFPBax and pEGFP-Bax(DS184) were a gift from Dr Richard Youle (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA).
Immunoblot assay
FL5.12 cells were lysed in Triton X-100 lysis buer (150 mM NaCl, 10 mM Tris-HCl [pH 8.0], 5 mM EDTA, 1% Triton X-100) containing protease inhibitors (1 mM PMSF, 5 mg/ml leupeptin, 5 mg/ml aprotinin and 1 mg/ml pepstatin A). Cell lysates were normalized for protein content and subjected to SDS ± PAGE/immunoblot analysis with antibodies speci®c for caspase-3 (Imgenex), cleaved D4-GDI (Imgenex), b-actin (Sigma), or Bid (Upstate Biotechnology, Inc.), followed by horseradish peroxidase-conjugated secondary antibodies (BD PharMingen) and detection by an enhanced chemiluminescence (ECL) system (Amersham Pharmacia Biotech).
Immunoprecipitation assay
Cells were lysed in Chaps lysis buer (150 mM NaCl, 10 mM HEPES [pH 7.4], 1% Chaps) or Triton X-100 lysis buer containing protease inhibitors. Immunoprecipitation and immunoblot assays were performed as described (Cuddeback et al., 2001) with the indicated antibodies.
Immunofluorescence analysis
FL5.12 cells were cultured with 25 nM of MitoTracker CMTMRos (Molecular Probes, Inc.) for 30 min prior to ®xation in 4% paraformaldehyde and permeabilization in 0.2% Chaps. Immuno¯uorescent staining was performed as described (Cuddeback et al., 2001 ) with anti-Bax 6A7 antibody (5 mg/ml, BD PharMingen) and FITC-conjugated secondary antibody (1:30, Dako). Nuclei were stained with 0.1 mg/ml of 4', 6-diamino-2-phenylinodole (DAPI) and analysed by a¯uorescence microscopy.
Subcellular fractionation
FL5.12 cells were washed in ice-cold PBS and resuspended in isotonic mitochondrial buer (210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM HEPES [pH 7.5]) containing protease inhibitors (Eskes et al., 2000) . Cells were homogenized by Dounce homogenizer and centrifuged at 1000 g for 10 min to pellet unbroken cells and nuclei. The resulting supernatant was then centrifuged at 13 000 g for 10 min to obtain heavy membrane fraction (pellet), and the supernatant was then centrifuged at 100 000 g for 90 min to obtain the cytosolic fraction (supernatant).
Detection of caspase-3 activity and mitochondrial membrane potential
The cell-permeable¯uorigenic substrate PhiPhiLux-G 2 D 2 was employed to determine caspase-3 like activity in intact cells, following the manufacturer's protocol (Oncolmmunin, Inc.). The cationic mitochondrion-selective dye MitoTracker CMTMRos (Molecular Probes, Inc.) was used to evaluate the mitochondrial inner membrane potential (DC m ).
